DSS, Inc.

DSS - Financial Snapshot

Metrics for DSS

Price $1.0
Shares Outstanding 9.99M
All-Time Low $0.72
52-Week Low $0.72

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
⇒ cashValuePerShare = ((8,680,000 - 66,015,000) / 9,992,518) = -5.7378
Net Current Assets / Share $-4.89
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
⇒ netCurrentAssetsPerShare = ((17,104,000 - 66,015,000) / 9,992,518) = -4.8948
Net Tangible Assets / Share $0.7
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
⇒ netTangibleAssetsPerShare = ((92,123,000 - 19,093,000 - 66,015,000) / 9,992,518) = 0.7
Shares Outstanding Ave Change (Annual) 26.61%
Shares Δ YoY 14.52%
Avg CA Burn (Annual %) 0.26% (as of 2-20-2026)
Avg CA Burn (Quarterly %) -24.54% (as of 2-20-2026)

Earning Metrics

Max Earning Power / Share $-1.05
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
⇒ maxEarningPowerPerShare = ((-1,104,000 / 0.105) / 9,992,518) = -1.0522
Adjusted Earning Power $-2.19
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-2,299,000 / 0.105) / 9,992,518) = -2.1912
Non-Cash Charges to Market Cap 10.91%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Avg EBITDA (5Y) 0 (as of 2-20-2026)
Avg EBITDA (5Q) 0 (as of 2-20-2026)
Avg Net Income (5Y) -50.1M (as of 2-20-2026)
Avg Net Income (5Q) -9.5M (as of 2-20-2026)
Data as of: Price 03-20-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Current Dividend Streak No 2-20-2026
Consecutive Years Paid No 2-20-2026
Pays Dividend No 2-20-2026
Last Dividend Date 5-7-20
Income indicators Value Date
EBITDA Positive No 2-20-2026
Net Income Positive No 2-20-2026
Current Dividend Streak No 2-20-2026

Metric History Explorer

Pick a metric to view its history table and chart.

Tangible Book Value Per Share History

Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.

Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).

Report Date Period TBV / Share Tangible Book Value Shares Used
2025-09-30 Quarterly $-0.54 -4.9M ($-4,890,000) 9.1M (9,092,518)
2025-06-30 Quarterly $-0.41 -3.7M ($-3,740,000) 9.1M (9,092,518)
2025-03-31 Quarterly $-0.27 -2.5M ($-2,473,000) 9.1M (9,092,518)
2024-12-31 Quarterly $-0.05 -420K ($-420,000) 8.1M (8,092,518)
2024-12-31 Annual $-0.05 -420K ($-420,000) 8.1M (8,092,518)
2024-09-30 Quarterly $0.86 6M ($6,045,000) 7.1M (7,066,772)
2023-12-31 Annual $2.39 16.9M ($16,872,000) 7.1M (7,066,772)
2022-12-31 Annual $4.96 34.5M ($34,484,000) 7M (6,950,858)
2021-12-31 Annual $16.69 66.5M ($66,540,000) 4M (3,987,294)

Dividend Payments

Historical cash dividends per share from Yahoo ex-dividend dates.

Date Dividend / Share
No dividend payment history available yet

Shares Outstanding Changes

Date Shares Outstanding Delta
2026-02-06 9,992,518 +900,000
2025-09-18 9,092,518 -2

Short Interest Changes

Latest short-interest change: 26,259 shares (0.70% of float) | Days to cover: 0.10

Date Short Interest Delta Δ %
2026-03-11 26,259 shares -8,873 -25.26%
2026-02-26 35,132 shares -36,717 -51.10%
2026-02-11 71,849 shares -9,958 -12.17%

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
2026-02-02 3,052,486 9,092,518 33.57% $1.18

DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, the company focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engages in nonbanking activities related to banking, such as loan syndication, mortgage banking, trust and escrow, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services; and operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as lists and operates as a digital asset on secondary market. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.